Business

Medexus to Participate in Fireside Chat at SHARE Series Event

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - August 4, 2023) - Medexus Pharmaceutica...

articleMedexus Pharmaceuticals Inc.August 4, 20235/company/medexus-pharmaceuticals-inc/news/medexus-to-participate-in-fireside-chat-at-share-series-event
Medexus to Participate in Fireside Chat at SHARE Series Event

About this update from Medexus Pharmaceuticals Inc.

[{"type":"text","content":"Medexus to Participate in Fireside Chat at SHARE Series EventToronto, Ontario and Chicago, Illinois--(Newsfile Corp. - August 4, 2023) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to announce that company management will present at the SHARE Series event on Monday, August 14, 2023 at 8:30 AM Eastern time.Event: SHARE SeriesDate: August 14, 2023Location: Virtual PresentationMedexus Presentation: Monday, August 14 at 8:30 AM Eastern timeKen d'Entremont, Medexus's Chief Executive Officer, and Marcel Konrad, Medexus's Chief Financial Officer, will conduct a 30-minute moderated fireside chat at 8:30 AM Eastern time. This fireside chat will include the opportunity for questions.The live stream of the Medexus presentation will be available on the Investors—News & Events section of Medexus's corporate website or at the following link:https://www.openexchange.tv/share-series An archived replay will be available on the SHARE Series website for approximately 90 days following the event. About MedexusMedexus is a leading specialty pharmaceutical company with a strong North American commercial platform and a growing portfolio of innovative and rare disease treatment solutions. Medexus's current focus is on the therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology. For more information about Medexus and its product portfolio, please see the company's corporate website at www.medexus.com and its filings on SEDAR+ at www.sedarplus.ca. ContactsKen d'Entremont | CEO, Medexus PharmaceuticalsTel: 905-676-0003 | Email: [email protected] Konrad | CFO, Medexus PharmaceuticalsTel: 312-548-3139 | Email: [email protected] Rutherford | Adelaide CapitalTel: 480-625-5772 | Email: [email protected] statementsCertain statements made in this news release contain forward-looking information within the meaning of applicable securities laws (forward-looking statements). The words \"anticipates\", \"believes\", \"expects\", \"will\", \"plans\", \"potential\", and similar words, phrases, or expressions are often intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words, phrases, or expressions. These statements are based on factors or assumptions that were applied in drawing a...

More updates from Medexus Pharmaceuticals Inc.